Objective-To investigate the functional role of the microRNA (miR)-15b/16 in vascular smooth muscle (SM) phenotypic modulation. Approach and Results-We found that miR-15b/16 is one of the most abundant mRs expressed in contractile vascular smooth muscle cells (VSMCs). However, when contractile VSMCs get converted to a synthetic phenotype, miR-15b/16 expression is significantly reduced. Knocking down endogenous miR-15b/16 in VSMCs attenuates SM-specific gene expression but promotes VSMC proliferation and migration. Conversely, overexpression of miR-15b/16 promotes SM contractile gene expression while attenuating VSMC migration and proliferation. Consistent with this, overexpression of miR-15b/16 in a rat carotid balloon injury model markedly attenuates injury-induced SM dedifferentiation and neointima formation. Mechanistically, we identified the potent oncoprotein yes-associated protein (YAP) as a downstream target of miR-15b/16 in VSMCs. Reporter assays validated that miR-15b/16 targets YAP's 3′ untranslated region. Moreover, overexpression of miR-15b/16 significantly represses YAP expression, whereas conversely, depletion of endogenous miR-15b/16 results in upregulation of YAP expression. and heart regeneration, 7,8 the functional role of miR-15/16 in VSMCs is unknown.
V ascular smooth muscle cells (VSMCs) comprise the majority of the wall of blood vessels. The main function of VSMCs is to regulate the caliber of blood vessels by involuntary vasoconstriction or vasodilation, thereby regulating blood flow and pressure. Mature VSMCs are quiescent and are geared for contraction through expressing a unique set of contractile proteins, including smooth muscle (SM) α-actin, SM myosin heavy chain, 130-kDa myosin light chain kinase, Hic-5, 1 calponin, and SM22 α. 2 However, unlike striated muscles, VSMCs exhibit an extraordinary phenotype plasticity where, in response to diverse environmental cues, the cells may switch from a contractile phenotype to a synthetic phenotype that is characterized by increased proliferation and motility and decreased expression of the contractile proteins. 2 Several serious pathological conditions in humans, such as intimal hyperplasia associated with restenosis, are largely dependent on VSMC phenotype modulation, contributing to progression of intimal lesions that lead to vessel occlusion. 2 Although several signaling pathways or factors have been reported to play roles in SM phenotypic switching, the mechanisms that control VSMC plasticity are still not fully understood.
MicroRNAs (miRs) are a class of small noncoding RNAs composed of 18-to 25-bp nucleotides. 3 Using the seed-binding sequence, miRs usually bind to the complementary 3′ untranslated regions (3′-UTRs) of the messenger RNA (mRNA) transcripts, thereby inhibiting gene expression through inducing translational repression or mRNA degradation. 3 The canonical miR-16 family shares the same seed-binding sequence AGCAGC; therefore, the members of miR-16 family likely have functional redundancy. 4 As defined by the sequence similarity, members of the miR-16 family include miR-15 (a and b), miR-16 (1 and 2), miR-195, miR-424, and miR-497. 4 Among them, miR-15 and miR-16 are co-transcribed from one of 2 different intragenic loci, miR-15a/miR-16-1 and miR-15b/miR-16-2, that are highly conserved among mammalian species. 5 Although previous studies have demonstrated that miR-15/16 clusters act as tumor suppressors 6 and play a critical role in the control of cardiomyocyte proliferation
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and heart regeneration, 7, 8 the functional role of miR-15/16 in VSMCs is unknown.
The Hippo signaling is an evolutionally conversed pathway that controls organ size and tumorigenesis. 9 Yesassociated protein (YAP) is a major downstream effector of this signaling pathway that is inactivated by phosphorylation by its upstream large tumor suppressor kinases. 9 YAP is overexpressed in a spectrum of human primary tumors and is a potent oncoprotein because of its ability to induce expression of genes involved in cell cycle progression. 9 Recently, several studies showed that the Hippo-YAP pathway plays a critical role in cardiovascular development 10, 11 and vascular disease in mouse. 12, 13 In particular, our recent study showed that YAP expression is induced during SM phenotypic modulation, and this increased expression of YAP inhibits SM-specific gene expression while promoting SM proliferation and migration in vitro and in vivo. 13 However, the mechanisms through which YAP is upregulated during SM phenotypic switching remains elusive.
In this study, we demonstrate that miR-15b/16 promotes VSMC contractile phenotype, at least in part, by targeting YAP, and therefore, restoring expression of miR-15/16 would be a potential therapeutic approach for treatment of proliferative vascular diseases.
Materials and Methods
Rat aortic SMCs were prepared as previously reported. 1 Rat carotid artery balloon injury was performed as described in our previous reports. 1, [12] [13] [14] Full Materials and Methods are available in the onlineonly Data Supplement.
Results

Expression of miR-15b/16 Is Downregulated During SM Phenotypic Switching From a Contractile to Synthetic State In Vitro and In Vivo
To explore the potential function of the miR-16 family miRs in VSMCs, we first examined their expression in vascular tissue and primary VSMCs. By quantitative reverse transcription polymerase chain reaction, we found miR-16 highly expressed in the rat thoracic aorta and found it to be ≈20% of miR-145, the most abundant miR that was previously identified in the vascular tissue [15] [16] [17] ( Figure IA in the onlineonly Data Supplement). Moreover, in both rat primary aortic SMCs and human coronary artery SMCs, miR-16 and its co-transcribed family member, miR-15b, are the most abundant miRs found among the miR-16 family ( Figure IB and IC in the online-only Data Supplement). Compared with endothelial cells and macrophages in mouse, primary VSMCs have highest expression level of miR-15b and miR-16 ( Figure  ID in the online-only Data Supplement). We therefore first examined the expression of miR-15b/16 during SM phenotypic switching in vitro and in vivo. In culture, rat aortic tissue undergoes a dramatic switch toward a synthetic proliferative phenotype 1, 18 that was associated with significantly decreased expression of miR-15b/16 along with SM contractile phenotype marker Hic-5 1 ( Figure 1A) . In response to plateletderived growth factor BB, a growth factor known to further inhibit SM contractile protein expression while promoting VSMC proliferation and migration, 19 expression of miR15b/16 was significantly downregulated, whereas expression of miR-221 was significantly induced as previously reported 20 ( Figure 1B) . Consistent with the in vitro data, we found that miR-15b/16 was significantly reduced in the balloon-injured rat carotid arteries, a model resembling angioplasty in humans that promotes VSMC proliferation and migration while reducing expression of SM differentiation markers ( Figure 1C ). 21 Taken together, these data demonstrate that expression of miR-15b/16 is attenuated in phenotypically modulated synthetic VSMCs in vitro and in vivo.
MiR-15b/16 Attenuates VSMC Proliferation and Migration
Proliferation and migration of VSMCs are key events for the development of neointima thickening. Because miR-15b/16 was reduced in phenotypically modulated VSMCs and these cells are known to be proliferative and migratory, we directly examined the effects of miR-15b/16 on VSMC proliferation and migration. Using WST-1 assays, we found that overexpression of miR-15b/16 (≈15-fold; Figure IIA in the online-only Data Supplement) significantly impaired VSMC proliferation in a variety of cell culture media (Figure 2A Figure 2B ), indicating a cell cycle arrest in G0/G1. This cell cycle retardation resulted in a significant decrease in cell growth ( Figure 2C ) of rat VSMCs and human coronary artery SMCs ( Figure 2D ). To test the functional role of endogenous miR-15b/16 on VSMC proliferation, we used antisense oligonucleotides to knock down endogenous miR15b/16. Quantitative reverse transcription polymerase chain reaction revealed that the endogenous miR-15b/16 was almost completely depleted after transfection with antisense oligonucleotide ( Figure IIB in the online-only Data Supplement). Silencing miR-15b/16 resulted in enhanced rates of VSMC proliferation and growth ( Figure 2E and 2F). Moreover, overexpression of miR-15b/16 in rat aortic primary SMCs also significantly attenuated VSMC migration as assessed by Boyden chamber assays ( Figure 2G ). In contrast, silencing endogenous miR-15b/16 promoted VSMC migration ( Figure 2H ).
Together, these data demonstrate that miR-15b/16 is a potent inhibitor for VSMC proliferation and migration.
MiR-15b/16 Promotes the Smooth Muscle Contractile Phenotype by Targeting YAP
Because miR-15b/16 was downregulated in tandem with the reduction of SM-specific markers during SM phenotypic switching (Figure 1 ), we next determined the role of miR15b/16 on SM differentiation. Overexpression of miR-15b/16 in rat primary aortic SMCs promoted the expression of SM contractile genes, including SM22α, Hic-5, SM α-actin, and calponin, whereas expression of proliferative markers, such as PCNA and cyclin D1, was decreased ( Figure 3A) . Similar results can be obtained in human coronary artery SMCs ( Figure 3B ). Recently, we showed that the expression of YAP is induced in all of in vitro and in vivo SM phenotypic modulation models as described in Figure 1 . 13 Furthermore, we found that the induced expression of YAP plays an integrated role in inhibiting SM-specific gene expression while promoting VSMC migration and proliferation. 13 Because the expression of miR-15b/16 and YAP is negatively correlated and their functions exert opposite effects in VSMCs, we postulated that YAP may be a potential target of miR-15b/16. Consistent with this idea, overexpression of miR-15b/16 was found to attenuate YAP protein expression without affecting expression of the YAP-associated protein, TEA domain family member 1 ( Figure 3A ). The inhibition of YAP by miR-15b/16 is through blocking of YAP translation because YAP mRNA levels were unaltered ( Figure 3C ). In contrast, a known miR-16 target, cyclin D1, 22 appeared to be regulated through altered mRNA stability ( Figure 3A and 3B). Furthermore, silencing endogenous miR-15b/16-induced YAP expression inhibited expression of SM-specific differentiation genes and upregulated cycline D1 expression ( Figure 3D ). Data from these gain/ loss-of-function assays suggest that YAP is a potential target of miR-15b/16. Targetscan.org and microRNA.org prediction algorithms indicated that the 3′-UTR of the human YAP gene harbors a putative consensus site for miR-15b/16, and this binding site is evolutionarily conserved among vertebrates ( Figure 3E ). To experimentally validate YAP as a miR-15b/16 target gene, we first generated luciferase reporters containing was transduced into rat primary aortic smooth muscle cells (SMCs), and then proliferation was measured using a cell proliferation WST-1 kit (Roche) in the culture media as indicated. *P<0.05. B, After transduction with miR-15b/16 or control GFP adenovirus, rat primary aortic SMCs were harvested for propidium iodide staining to analyze cell cycle by a flow cytometry. *P<0.05. C, After overexpression of miR-15b/16, rat primary aortic SMCs were seeded at equal density at day (D) 0 and counted at each time point as indicated. N=3. *P<0.05. D, Human coronary artery SMCs (HCASMCs) were transduced by control GFP or miR-15b/16 virus, and cell numbers were counted as described in C. E, WST-1 assay was performed in rat primary aortic SMCs cultured in the different culture media as indicated after transfection either with control or with antisense oligonucleotides against miR-15b/16. *P<0.05. F, After silencing miR-15b/16, rat primary aortic SMCs were seeded at equal density at day (D) 0 and counted at each time point as indicated. N=3. *P<0.05. G, Quantification of Boyden chamber assay to assess cell migration after 4 hours plating of rat aortic SMCs cells that were transduced by either GFP or miR-15b/16 adenovirus. *P<0.05. H, Control or miR-15b/16 antisense oligonucleotides were transfected into rat aortic SMCs, and the Boyden chamber assay was performed to examine cell migration. *P<0.05. PDGF-BB indicates platelet-derived growth factor BB.
by guest on July 8, 2017 http://atvb.ahajournals.org/ Downloaded from the YAP 3′-UTR region harboring the wild-type or mutated putative miR-15b/16-binding site, and then transient transfection experiments were performed. Data from these experiments revealed that luciferase activity of the wild-type YAP 3′-UTR luciferase reporter was significantly decreased in a dosedependent manner in the presence of miR-15b/16, whereas luciferase activity of constructs in which the miR-15b/16-binding site was mutated was unaffected by miR-15b/16 overexpression ( Figure 3F ). To further determine the role of YAP in the miR-15b/16-mediated inhibition of VSMC growth, adenovirus encoding miR-15b/16 was co-transduced into rat primary aortic SMCs with or without YAP adenovirus, which lacks its 3′-UTR, and then the SMC growth was evaluated by WST-1 assays and cell number counting. Data from these experiments revealed that in the presence of YAP lacking its 3′-UTR, the miR-15b/16-mediated VSMC growth inhibition was . A, Adenovirus expressing green fluorescent protein (GFP) or miR-15b/16 was transduced into rat primary aortic smooth muscle cells (SMCs) for 3 days. Subsequently, protein was collected for Western blot. B, Human coronary artery SMCs (HCASMCs) were transduced with GFP or miR-15b/16 adenovirus, and Western blot was performed to examine the protein expression as described in A. C, Total RNA was harvested from the rat primary aortic SMCs that were infected with GFP or miR-15b/16 adenovirus, and quantitative reverse transcription polymerase chain reaction (qRT-PCR) was performed to measure mRNA expression as indicated. *P<0.05. D, Control or miR-15b/16 antisense oligonucleotides were transfected into rat primary aortic SMCs for 3 days, and protein was harvested for Western blot as indicated. E, Schematic diagram of the luciferase reporters harboring wild-type (WT) or mutation of the miR-16-binding site in the 3′ untranslated regions (3′-UTR) of human YAP. The shaded region indicates an evolutionarily conserved seed-binding sequence among vertebrate species for miR-15b/16 recognition. The mutated nucleotides in YAP 3′-UTR reporter were underscored. F, The luciferase reporter constructs harboring WT or mutation of predicted miR-16-binding site of YAP 3′-UTR were co-transfected with the increasing amount of miR-15b/16 plasmid into HEK293 cells. Thirty-six hours after transfection, cells were harvested for dual luciferase assays. Reporter activity is normalized to a renilla luciferase internal control and expressed relative to the transfection with empty plasmid (set to 1). Data were presented as mean±SE of 6 samples. *P<0.05. G, Rat primary aortic SMCs were transduced with the combination of GFP, miR-15b/16, or YAP as indicated for 2 days and then WST1 assays were performed to assess the cell proliferation, and cell numbers were counted at the time points as indicated (H). miR-15b/16 or YAP vs GFP, *P<0.05; YAP+miR-15b/16 vs miR-15b/16, 
Restoring the Expression of miR-15b/16 Attenuates Arterial Injury-Induced Neointima Formation in the Rat Carotid Artery Balloon Injury Model
Given that miR-15b/16 strongly inhibits VSMC proliferation and migration while promoting SMC contractile gene expression through targeting YAP in vitro (Figure 2 and 3) , we next tested miR-15b/16 function in vivo in the rat carotid artery balloon injury model. After the protocol we recently established for the local viral infusion in the balloon-injured carotid artery, 13 we first confirmed that local delivery of miR15b/16 adenovirus increased the expression of miR-15b/16 2-to 4-folds compared with the control right carotid artery ( Figure 4A ). Moreover, overexpression of miR-15b/16 in vivo significantly inhibited neointima formation as measured by decreased neointima/media ratio and reduced neointima area as compared with control green fluorescent protein virustransduced carotid arteries ( Figure 4B-4D ). These data demonstrate that restoring the expression of miR-15b/16 attenuates arterial injury-induced neointima formation in the rat carotid artery balloon injury model.
Overexpression of miR-15b/16 Promotes VSMC Contractile Phenotype In Vivo
Previously we have shown that the expression of YAP was significantly induced in rat balloon injury model, and blocking the induction of YAP significantly upregulated SM marker expression and decreased SMC proliferation, thereby attenuating neotima formation after arterial injury. 13 Because overexpression of miR-15b/16 in vivo attenuated neointima formation after arterial injury ( Figure 4 ) and YAP was identified as a direct target of miR-15b/16 ( Figure 3) , we sought to determine whether the beneficial effects of miR-15b/16 were associated with decreased YAP expression in vivo. Western blotting of proteins isolated from either green fluorescent protein control or miR-15b/16 virus-treated vessels 14 days after balloon injury revealed that exogenous overexpression of miR-15/16 impeded the arterial injury-induced YAP expression and significantly alleviated injury-induced downregulation of SM-specific differentiation genes ( Figure 5A and 5B). Furthermore, overexpression of miR-15b/16 significantly decreased neointima VSMC proliferation by 40% as indicated by Ki-67 staining ( Figure 5C and 5D ). Taken together, these data demonstrate that miR-15b/16 promotes the VSMC contractile phenotype by targeting YAP, thereby attenuating arterial injury-induced neointima formation ( Figure 5E ).
Discussion
This study provides the first evidence demonstrating a novel role for miR-15b/16 in targeting YAP to regulate the phenotype of VSMCs. We found that miR-15b/16 was highly expressed in contractile VSMCs and was downregulated in phenotypically modified VSMCs concomitant with increased YAP expression ( Figure I in the online-only Data Supplement and Figure 1) . 13 We identified YAP as a direct downstream target of miR-15b/16 ( Figure 3E and 3F) . Because miR15b and miR-16 share the identical seed sequence to bind to YAP 3′UTR, it is conceivable that individual miR-15b and miR-16 have similar effects on YAP 3′UTR reporter activity. Furthermore, we found that overexpression of miR-15/16 significantly represses YAP expression in vitro and in vivo ( Figure 3A and 3B and Figure 5A ). Conversely, depletion of endogenous miR-15b/16 resulted in an upregulation of YAP expression and decreased expression of contractile proteins ( Figure 3D ). Therefore, our study suggests that the downregulation of miR-15b/16 in response to vascular injury alleviates its repression of YAP in vitro and in vivo, permitting YAP to drive VSMC from a contractile phenotype toward a synthetic proliferative phenotype. In further support of the negative relationship between miR-15b/16 and YAP expression, The expression of miRs in control RCA in each group was set to 1. N=7 each group. B, Fourteen days after injury, carotid artery sections from either control or balloon-injured vessels that were transduced with GFP or miR-15b/16 adenovirus were prepared for hematoxylin and eosin staining (H&E) staining. Statistical analysis of neointima/media layer ratio (C) and neointima area (D) of sections shown in the B using ImageJ software. N=7. *P<0.05. AD indicates adventitial layer; M, media; and NI, neointima.
previous studies have shown that miR-16 family members are drastically upregulated, 8 whereas the expression of YAP is significantly downregulated during the arrest of cardiomyocyte proliferation in the postnatal mouse heart. 23 Similarly, the expression of a subset of miR-16 family miRs is strikingly upregulated during the maturation of mouse aorta when the VSMCs transit from a proliferative to a quiescent phenotype. 24 In addition to directly targeting YAP, it is likely that miR15b/16 modulates VSMC proliferation by also targeting YAPregulated genes that control cell cycle. The miR-16 family has been proposed to be a set of master inhibitors for cell proliferation by silencing many overlapping target genes involved in the cell cycle progression, especially G1-S transition, including cyclin D1, cyclin E1, and cdc25A. 22, 25 Furthermore, several other cell cycle genes were revealed to be regulated by miR-16 family, including cyclin D2, cyclin D3, cyclin-dependent kinase 6, check point kinase 1, cdc2, Birc5, and cdc42. 4 YAP activates a spectrum of genes involving in cell cycle that significantly overlap with the miR-16 family targets, including cyclin D1, cyclin E1, check point kinase 1, cdc2, and Birc5. 8, 23, 26, 27 Among these, cyclin D1 was initially identified as a bona fide target gene of YAP 26 and can be targeted by miR-16 to both promote mRNA degradation and inhibit protein translation. 22 Previous study has shown that increased cyclin D1 expression was sufficient to mediate the injuryinduced neointima formation by promoting VSMC proliferation. 28 Moreover, we have shown that YAP can induce cultured VSMC proliferation in vitro through induction of cyclin D1. 13 Together, these findings suggest that the inhibitory effects of overexpressed miR-15b/16 on neotima formation in vivo likely result from a combination of its ability to target both YAP and cyclin D1. Therefore overexpression of miR-15b/16 would have more potent inhibitory effects on SM cell proliferation than silencing YAP alone because miR-15b/16 may target additional cell cycle regulators other than the shared target cyclin D1 with YAP. Although miR-195, another member of the miR-16 family, has been reported to inhibit VSMC proliferation, 29 we found that expression of miR-195 is low compared with the expression of miR-15b/16 in VSMCs ( Figure I in the online-only Data Supplement).
In this study, we provide a novel mechanistic insight into the post-transcriptional regulation of YAP expression in VSMCs by miR-15b/16. Because YAP protein is overexpressed in an array of tumors in humans and in injured vessels, studying the regulation of endogenous YAP expression is of great clinical importance. Initial studies have concentrated on investigating YAP phosphorylation, degradation, and nuclear localization. 9 However, emerging evidences suggest that the expression of YAP can be regulated at both transcriptional and post-transcriptional levels. For example, c-Jun, 30 β-catenin, 31 cAMP response element-binding protein, 32 and the Ets family member GA-binding protein 33 can regulate YAP gene transcription. Recently, the activating transcription factor, ATF-4, has also been shown to promote YAP transcriptional induction in the cells experiencing endoplasmic reticulum stress, thereby promoting cell survival. 34 YAP expression is known to be regulated post-transcriptionally by several miRs. During preparation of the article, we noticed that miR-15a/16 targeted YAP to inhibit cell proliferation and migration in gastric adenocarcinoma cells. 35 In addition to miR-16 family members, YAP can be regulated by miR-375 in liver, 36 lung, 37 pancreatic cancer cell, 38 and thyroid cancer cell. 39 Additionally, miR-141, -200a, and -506 have been implicated in regulating YAP expression in esophageal squamous cell carcinoma, 40 breast cancer cell, 41 and hepatoma cancer cell, 42 respectively. A recent report also demonstrated that YAP can be regulated at the epigenetic level. 43 Together, these studies suggest that regulation of YAP gene expression is complex and is developmental stage-, cell-and tissue context-dependent. Interestingly, in this study, we found overexpression of miR-15b/16 specifically downregulates YAP protein expression without affecting YAP mRNA expression level ( Figure 3A-3C) , suggesting that the inhibitory effects of miR-15b/16 is through suppressing the translation of YAP. However, we previously reported that YAP protein and mRNA levels are both increased after vascular injury, 13 suggesting that miR-15b/16-mediated decrease in YAP protein expression are only a part of mechanism accounting for increased YAP expression after vascular injury. Given that ATF-4 promotes YAP expression 34 and ATF-4 is induced in VSMCs after arterial injury to mediate neointima thickening, 44 it is likely that ATF-4 plays a role in the transcriptional upregulation of YAP in VSMCs after injury. Additional studies are needed to confirm this possibility.
Restoring expression of miR-15b/16 after balloon injury significantly attenuated neointima formation (Figure 4 and 5). This data together with strong effects of miR-15b/16 on promoting VSMC contractile phenotype suggest that overexpression of miR-15b/16 family may be an attractive therapeutic strategy for treating proliferative VSMC-related diseases, such as atherosclerosis and restenosis. However, the potent ability of miR-16 family to inhibit cell proliferation may be a double-edged sword because it also affects endothelial cell proliferation and migration that is involved in angiogenesis and re-endothelialization. 45, 46 Therefore, any therapies aimed at targeting miR-16 family in the cardiovascular system are required to be cell type-specifically targeted.
In summary, this study identifies miR-15b/16 as a critical modulator in promoting VSMC contractile phenotype by targeting, at least in part, YAP. Therefore, restoring miR-15b/16 expression in the VSMCs would be an attractive therapeutic approach for treatment of VSMC-related occlusive vascular diseases.
1
SUPPLEMENTAL MATERIAL Supplemental Methods
Primary VSMC culture and PDGF-BB treatment. Rat arterial tissues were harvested and rat primary aortic SMCs were prepared and cultured as described in our previous reports [1] [2] [3] . Briefly, male Sprague-Dawley rats (200-250 grams; Taconic Farms, Germantown, NY) were euthanized by CO 2 and the thoracic aorta was dissected to remove adhering periadventitial tissue and the endothelium was denuded with a catheter. The aorta either was directly harvested for total RNA exaction or was digested with a Blend enzyme III solution (Roche, 0.5U/ml) for 10 min at 37°C
followed by dissection to remove the adventitial layer, then the remaining medial layer was minced into small pieces for a second digestion with Blend enzyme III for 2 hours at 37°C.
Following removal of digestion solution and re-suspending in 10% FBS DMEM medium, cells
were gently liberated with a pipette and transferred into culture dishes. Every batch of smooth muscle cells was tested by smooth muscle marker SM α-actin staining to ensure the purity of primary VSMCs above 95%. Human coronary artery SMCs were purchased from Invitrogen (catalog number: C-017-5C) and cultured essentially following the manufacturer's protocol. All SMC cultures used in this study were less than 6 passages. For PDGF-BB treatment experiments, rat primary aortic VSMCs were grown to 80-90% confluence and serum-starved for 24 hours and then treated with recombinant rat 50 ng/ml PDGF-BB (platelet-derived growth factor BB, Calbiochem) for 48 hours as described in our previous reports 1, 2 . Cells treated with vehicle served as control. Following PDGF-BB or vehicle administration cells were harvested for total RNA to detect microRNA expression by qRT-PCR. qRT-PCR analysis for gene expression. Total RNA from rat primary VSMCs was isolated with
TRIzol reagent and qRT-PCR was performed with respective gene-specific primers as we previously reported [1] [2] [3] [4] [5] [6] . All samples were amplified in duplicate and every experiment was repeated independently 2 times. Relative gene expression was converted using the 2 -!!ct method against the internal control acidic ribosomal phosphoprotein P0 (RPLP0) house-keeping gene.
Generation of adenovirus for expression of rat miR-15b/16. A 600-bp fragment spanning the genomic region of rat miR-15b and miR-16-2 cluster was amplified by PCR using rat brain genomic DNA as a template (see the primer sequences in the Online Table 1 ) and cloned into a Images were taken by ImageQuan LAS4000 Imaging Station (GE) and band densities were quantified using the ImageQuant TL software (GE).
Dual luciferase reporter assay. For generating human YAP 3'-UTR reporter, a 1.8-k bp fragment of YAP 3'-UTR containing a putative miR-16 binding site was amplified by PCR with primers harboring SacI and PmeI restriction enzyme sites (primer sequences were listed in the Online Table I ) from human genomic DNA and then inserted to 3' of the firefly luciferase gene in pMir-report vector (Ambion). Mutation of miR-16 seeding site in YAP 3'-UTR was carried out with QuickChange Site-Directed Mutagenesis kit (Stratagene). All plasmids were sequenced to verify the integrity of the insert. Transfection in HEK293 cells was carried out with X-tremeGENE 9 transfection reagent (Roche) as previously described 1, 6, 9 . The level of luciferase activity was evaluated by measurement of the firefly luciferase activity relative to the internal control TKrenilla luciferase activity using the Dual Luciferase Assay System essentially as described by the manufacturer (Promega). A minimum of six independent transfections were performed and all assays were replicated at least twice. Results are reported as the mean ± SE.
Adenoviral infusion in rat carotid balloon angioplasity. Adenovirus expressing miR-15b/16
or GFP was generated as described above and purified using Fast-Trap adenovirus purification and concentration kit by EMD Millipore. Rat balloon angioplasty was carried out as previously described 8, 10 . Briefly, male Sprague-Dawley rats (350 g; Taconic Farms, Germantown, NY)
were anesthetized with xylazine 4.6 mg/kg and ketamine 70 mg/kg via intraperitoneal injection.
Following a midline cervical incision and muscular tissues separation, the left common carotid artery was exposed and blunt dissection was performed alongside the artery by dull forceps to expose the carotid artery bifurcation into the internal/external branches. Blood flow cessation was achieved by arterial clamps and a small arteriotomy was made in the external carotid artery.
A 2F Fogarty balloon embolectomy (Edwards) was inserted through the small cut and passed into the common carotid artery. After balloon inflation at 1.6-2.0 atm of pressure, the catheter was partially withdrawn and reinserted 3 times. Concentrated adenoviral solutions encoding GFP or miR-15b/16 (100µl each) were infused into the injured segment of the common carotid artery and incubated for 30 minutes. After the viral treatment, residual viral solutions in lumen were aspirated to avoid viral solutions into the systemic circulation. A permanent ligation was then placed in the external carotid artery, and the blood flow in the common carotid artery and its internal branch was restored by releasing arterial clamps. The right intact carotid artery served as a contralateral control. The use of experimental rats for arterial injury procedures, including BSL-2 viral work was approved by the IACUC and Biosafety committees at Georgia Regents University.
Sections, hematoxylin & eosin (H&E) staining, immunofluorescence (IF).
Rats were euthanized by asphyxiation with CO 2 and fragments of carotid arteries were fixed with 4% paraformaldehyde overnight at 4°C and embedded in paraffin for histological assays as described in our previous reports 2, 6, 8 . Sections were cut at 7-um thickness, deparaffinized and antigen retrieval was done by using microwave to heat at 98°C for 5 minutes in citric acid buffer Statistical analysis. Data are expressed as means ± SE, and statistical analysis using unpaired t test (two group comparison) or two-way ANOVA (multiple group comparison) was done with Prism software (Graphpad). Differences with p values < 0.05 were considered significant.
